ID   SARM1_RAT               Reviewed;         724 AA.
AC   D3ZUM2;
DT   10-FEB-2021, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   02-OCT-2024, entry version 99.
DE   RecName: Full=NAD(+) hydrolase SARM1 {ECO:0000305};
DE            Short=NADase SARM1 {ECO:0000305};
DE            EC=3.2.2.6 {ECO:0000250|UniProtKB:Q6SZW1};
DE   AltName: Full=NADP(+) hydrolase SARM1 {ECO:0000305};
DE            EC=3.2.2.- {ECO:0000250|UniProtKB:Q6SZW1};
DE   AltName: Full=Sterile alpha and TIR motif-containing protein 1 {ECO:0000303|PubMed:32968873};
DE   Flags: Precursor;
GN   Name=Sarm1 {ECO:0000303|PubMed:32968873, ECO:0000312|RGD:1310078};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PHOSPHORYLATION AT SER-548, AND MUTAGENESIS OF SER-548.
RX   PubMed=32968873; DOI=10.1007/s12035-020-02132-9;
RA   Xue T., Sun Q., Zhang Y., Wu X., Shen H., Li X., Wu J., Li H., Wang Z.,
RA   Chen G.;
RT   "Phosphorylation at S548 as a functional switch of Sterile Alpha and TIR
RT   Motif-containing 1 in cerebral ischemia/reperfusion injury in rats.";
RL   Mol. Neurobiol. 58:453-469(2021).
CC   -!- FUNCTION: NAD(+) hydrolase, which plays a key role in axonal
CC       degeneration following injury by regulating NAD(+) metabolism. Acts as
CC       a negative regulator of MYD88- and TRIF-dependent toll-like receptor
CC       signaling pathway by promoting Wallerian degeneration, an injury-
CC       induced form of programmed subcellular death which involves
CC       degeneration of an axon distal to the injury site. Wallerian
CC       degeneration is triggered by NAD(+) depletion: in response to injury,
CC       SARM1 is activated and catalyzes cleavage of NAD(+) into ADP-D-ribose
CC       (ADPR), cyclic ADPR (cADPR) and nicotinamide; NAD(+) cleavage promoting
CC       cytoskeletal degradation and axon destruction. Also able to hydrolyze
CC       NADP(+), but not other NAD(+)-related molecules. Can activate neuronal
CC       cell death in response to stress. Regulates dendritic arborization
CC       through the MAPK4-JNK pathway. Involved in innate immune response:
CC       inhibits both TICAM1/TRIF- and MYD88-dependent activation of JUN/AP-1,
CC       TRIF-dependent activation of NF-kappa-B and IRF3, and the
CC       phosphorylation of MAPK14/p38. {ECO:0000250|UniProtKB:Q6PDS3,
CC       ECO:0000250|UniProtKB:Q6SZW1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide;
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000250|UniProtKB:Q6SZW1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000250|UniProtKB:Q6SZW1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) = cyclic ADP-beta-D-ribose + H(+) + nicotinamide;
CC         Xref=Rhea:RHEA:38611, ChEBI:CHEBI:15378, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:73672;
CC         Evidence={ECO:0000250|UniProtKB:Q6SZW1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38612;
CC         Evidence={ECO:0000250|UniProtKB:Q6SZW1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NADP(+) = ADP-D-ribose 2'-phosphate + H(+) +
CC         nicotinamide; Xref=Rhea:RHEA:19849, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:58673; Evidence={ECO:0000250|UniProtKB:Q6SZW1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19850;
CC         Evidence={ECO:0000250|UniProtKB:Q6SZW1};
CC   -!- ACTIVITY REGULATION: Autoinhibited: in the inactive state, the
CC       enzymatic TIR domain is held apart by the autoinhibiting ARM repeats.
CC       NAD(+)-binding to ARM repeats maintains an inactive state by promoting
CC       interaction between ARM repeats and the TIR domain, thereby
CC       facilitating inhibition of the enzymatic TIR domain. Following
CC       activation, possibly by nicotinamide mononucleotide (NMN), auto-
CC       inhibitory interactions are released, allowing self-association of the
CC       TIR domains and subsequent activation of the NAD(+) hydrolase (NADase)
CC       activity. Self-association of TIR domains is facilitated by the octamer
CC       of SAM domains. {ECO:0000250|UniProtKB:Q6SZW1}.
CC   -!- SUBUNIT: Homooctamer; forms an octameric ring via SAM domains.
CC       Interacts with TICAM1/TRIF and thereby interferes with TICAM1/TRIF
CC       function. Interacts with MAPK10/JNK3 and SDC2 (via cytoplasmic domain).
CC       {ECO:0000250|UniProtKB:Q6PDS3, ECO:0000250|UniProtKB:Q6SZW1}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q6SZW1}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q6PDS3}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q6PDS3}. Synapse
CC       {ECO:0000250|UniProtKB:Q6PDS3}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q6SZW1}. Note=Associated with microtubules.
CC       {ECO:0000250|UniProtKB:Q6PDS3}.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000250|UniProtKB:Q6SZW1}.
CC   -!- DOMAIN: The ARM repeats inhibit the NAD(+) hydrolase (NADase) activity
CC       by binding to NAD(+): NAD(+)-binding to ARM repeats facilitates
CC       inhibition of the TIR domain NADase through their domain interface. In
CC       contrast to classical ARM repeats, the last helix of ARM 6 does not
CC       fold back to interact with the first two helices, but instead turns
CC       towards the N-terminus of SARM1. As a result, the two following motifs
CC       ARM 7 and ARM 8 reverse their directions and lie perpendicularly.
CC       Moreover, ARM repeats interact with different domains not only within
CC       each protomer but also of the adjacent ones.
CC       {ECO:0000250|UniProtKB:Q6SZW1}.
CC   -!- PTM: Phosphorylation at Ser-548 by JNK kinases (MAPK8, MAPK9 and /or
CC       MAPK10) enhance the NAD(+) hydrolase (NADase) activity
CC       (PubMed:32968873). Phosphorylation at Ser-548 and subsequent activation
CC       takes place in response to oxidative stress conditions and inhibits
CC       mitochondrial respiration (By similarity). Phosphorylation at Ser-548
CC       increases in response to cerebral ischemia/reperfusion (I/R) injury
CC       (PubMed:32968873). {ECO:0000250|UniProtKB:Q6SZW1,
CC       ECO:0000269|PubMed:32968873}.
CC   -!- SIMILARITY: Belongs to the SARM1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07030074; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473948; EDM05357.1; -; Genomic_DNA.
DR   RefSeq; NP_001099287.1; NM_001105817.1.
DR   AlphaFoldDB; D3ZUM2; -.
DR   SMR; D3ZUM2; -.
DR   STRING; 10116.ENSRNOP00000013639; -.
DR   iPTMnet; D3ZUM2; -.
DR   PhosphoSitePlus; D3ZUM2; -.
DR   jPOST; D3ZUM2; -.
DR   PaxDb; 10116-ENSRNOP00000013639; -.
DR   PeptideAtlas; D3ZUM2; -.
DR   Ensembl; ENSRNOT00000013639.6; ENSRNOP00000013639.5; ENSRNOG00000010244.6.
DR   Ensembl; ENSRNOT00055044562; ENSRNOP00055036468; ENSRNOG00055025827.
DR   Ensembl; ENSRNOT00060032893; ENSRNOP00060026891; ENSRNOG00060019012.
DR   GeneID; 287545; -.
DR   KEGG; rno:287545; -.
DR   AGR; RGD:1310078; -.
DR   CTD; 23098; -.
DR   RGD; 1310078; Sarm1.
DR   eggNOG; KOG3678; Eukaryota.
DR   GeneTree; ENSGT00390000004155; -.
DR   HOGENOM; CLU_003286_2_0_1; -.
DR   InParanoid; D3ZUM2; -.
DR   OMA; KSCEVQT; -.
DR   OrthoDB; 5475697at2759; -.
DR   PhylomeDB; D3ZUM2; -.
DR   TreeFam; TF315263; -.
DR   Reactome; R-RNO-166166; MyD88-independent TLR4 cascade.
DR   Reactome; R-RNO-936964; Activation of IRF3, IRF7 mediated by TBK1, IKKEpsilon (IKBKE).
DR   Reactome; R-RNO-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-RNO-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   PRO; PR:D3ZUM2; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000010244; Expressed in frontal cortex and 11 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0099243; C:extrinsic component of synaptic membrane; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005874; C:microtubule; ISO:RGD.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0003953; F:NAD+ nucleosidase activity; ISO:RGD.
DR   GO; GO:0061809; F:NAD+ nucleotidase, cyclic ADP-ribose generating; ISO:RGD.
DR   GO; GO:0035591; F:signaling adaptor activity; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0099010; P:modification of postsynaptic structure; IDA:SynGO.
DR   GO; GO:0019677; P:NAD catabolic process; ISO:RGD.
DR   GO; GO:0034128; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0050877; P:nervous system process; ISO:RGD.
DR   GO; GO:0070585; P:protein localization to mitochondrion; ISO:RGD.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:1905806; P:regulation of synapse pruning; ISO:RGD.
DR   GO; GO:0048678; P:response to axon injury; ISO:RGD.
DR   GO; GO:0009749; P:response to glucose; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd09501; SAM_SARM1-like_repeat1; 1.
DR   CDD; cd09502; SAM_SARM1-like_repeat2; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   Gene3D; 3.40.50.10140; Toll/interleukin-1 receptor homology (TIR) domain; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR039184; SARM1.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR22998:SF1; NAD(+) HYDROLASE SARM1; 1.
DR   PANTHER; PTHR22998; SARM1; 1.
DR   Pfam; PF07647; SAM_2; 2.
DR   Pfam; PF13676; TIR_2; 1.
DR   SMART; SM00454; SAM; 2.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 2.
DR   SUPFAM; SSF52200; Toll/Interleukin receptor TIR domain; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 2.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   Cell projection; Cytoplasm; Differentiation; Hydrolase; Immunity;
KW   Innate immunity; Mitochondrion; NAD; Neurogenesis; Phosphoprotein;
KW   Reference proteome; Repeat; Synapse; Transit peptide.
FT   TRANSIT         1..27
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250|UniProtKB:Q6SZW1"
FT   CHAIN           28..724
FT                   /note="NAD(+) hydrolase SARM1"
FT                   /id="PRO_0000452004"
FT   REPEAT          60..100
FT                   /note="ARM 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          114..153
FT                   /note="ARM 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          155..193
FT                   /note="ARM 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          196..235
FT                   /note="ARM 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          237..280
FT                   /note="ARM 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          281..314
FT                   /note="ARM 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          315..354
FT                   /note="ARM 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          359..402
FT                   /note="ARM 8"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          412..476
FT                   /note="SAM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          486..548
FT                   /note="SAM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          560..703
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   REGION          703..724
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        703..718
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        642
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   BINDING         103
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_label="1"
FT                   /ligand_note="inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q6SZW1"
FT   BINDING         110
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_label="1"
FT                   /ligand_note="inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q6SZW1"
FT   BINDING         149..157
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_label="1"
FT                   /ligand_note="inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q6SZW1"
FT   BINDING         190..193
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_label="1"
FT                   /ligand_note="inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q6SZW1"
FT   BINDING         569..570
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_label="2"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   BINDING         599
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_label="2"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   MOD_RES         548
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:32968873"
FT   MOD_RES         558
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PDS3"
FT   MUTAGEN         548
FT                   /note="S->A: Reduced infarct size, neuronal death and
FT                   neurobehavioral dysfunction in response to cerebral
FT                   ischemia/reperfusion (I/R) injury."
FT                   /evidence="ECO:0000269|PubMed:32968873"
SQ   SEQUENCE   724 AA;  79688 MW;  69C5AC996CB2A2D3 CRC64;
     MVLTLLFSAY KLCRFFIMSG PRPGADRLTV PGPDRSGGTS PWWAAGGRGS REVSPGVGTE
     VQGALERSLP ELQQALSELK QASAAQAVGA GLAEVFQLVE EAWLLPAVGR EVAQGLCDAI
     RLDGGLDLLL RLLQAPELET RVQAARLLEQ ILVAENRDRV ARIGLGVILN LSKEREPVEL
     ARSVAGILEH MFKHSEETCQ RLVAAGGLDA VLYWCRRTDP ALLRHCALAL ANCALHGGQT
     VQRCMVEKRA AEWLFPLAFS KEDELLRLHA CLAVAVLATN KEVEREVEHS GTLALVEPLV
     ASLDPGRFAR CLVDASDTSQ GRGPDDLQSL VLLLDSSRLE AQCIGAFYLC AEAAIKSLQG
     KTKVFSDIGA IQSLKRLVSY STNGTTSTLA KRALRLLGEE VPRRILPCVA SWKEAEVQTW
     LQQIGFSQYC ENFRDQQVDG DLLLRLTDEE LQTDLGMKSS ITRKRFFREL TELKTFASYA
     TCDRSNLADW LGSLDPRFRQ YTYGLVSCGL DRSLLHRVSE QQLLEDCGIR LGVHRTRILS
     AAREMLHSPL PCTGGKPSGD TPDVFISYRR NSGSQLASLL KVHLQLHGFS VFIDVEKLEA
     GKFEDKLIQS VMAARNFVLV LSAGALDKCM QDHECKDWVH KEIVTALSCS KNIVPIIDGF
     EWPEPQALPE DMQAVLTFNG IKWSHEYQEA TIEKIIRFLQ GRPSQDSSAG SDTSLEGATS
     MGLP
//
